CSIMarket
 


Quidelortho Corp  (QDEL)
Other Ticker:  
 
 

QDEL's Income Taxes Growth by Quarter and Year

Quidelortho's Income Taxes results by quarter and year




QDEL Income Taxes (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter January - 10.81 84.06 145.38
III Quarter October -2.80 12.10 65.74 63.51
II Quarter July -11.20 23.60 2.61 12.54
I Quarter April 11.20 140.69 43.72 8.60
FY   -2.80 187.20 196.13 230.03



QDEL Income Taxes third quarter 2023 Y/Y Growth Comment
Quidelortho Corp in the third quarter 2023 recorded Provisions for income taxes of $ -2.80 millions.

According to the results reported in the third quarter 2023, Quidelortho Corp achieved the best Income Taxes growth in In Vitro & In Vivo Diagnostic Substances industry. While Quidelortho Corp' s Income Taxes no change of % ranks overall at the positon no. 1119 in the third quarter 2023.

Explain Operating Income growth


QDEL Income Taxes ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter January - -87.14 % -42.18 % 7592.06 %
III Quarter October - -81.59 % 3.51 % 4604.44 %
II Quarter July - 804.21 % -79.19 % -
I Quarter April -92.04 % 221.8 % 408.37 % 397.11 %
FY   - -4.55 % -14.74 % 5299.77 %

Financial Statements
Quidelortho's third quarter 2023 Income Taxes $ -2.80 millions QDEL's Income Statement
Quidelortho's third quarter 2022 Income Taxes $ 12.10 millions Quarterly QDEL's Income Statement
New: More QDEL's historic Income Taxes Growth >>


QDEL Income Taxes (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter January - -10.66 % 27.87 % 128.91 %
III Quarter October - -48.73 % 2418.77 % 406.46 %
II Quarter July - -83.23 % -94.03 % 45.81 %
I Quarter April 3.61 % 67.37 % -69.93 % 355.03 %
FY (Year on Year)   - -4.55 % -14.74 % 5299.77 %




Income Taxes third quarter 2023 Y/Y Growth Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry #1
Healthcare Sector #117
Overall #1119

Income Taxes Y/Y Growth Statistics
High Average Low
5303.62 % -112.25 % -8471.32 %
(Dec 31 2020)   (Dec 31 2018)
Income Taxes third quarter 2023 Y/Y Growth Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry #1
Healthcare Sector #117
Overall #1119
Income Taxes Y/Y Growth Statistics
High Average Low
5303.62 % -112.25 % -8471.32 %
(Dec 31 2020)   (Dec 31 2018)

Income Taxes by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Quidelortho's Q/Q Income Taxes Growth


Income Taxes Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


QDEL's III. Quarter Q/Q Income Taxes Comment
Although Quidelortho Corp in the III. Quarter 2023 showed Provisions for income taxes of $ -2.80 millions, it should be point out, that current results show improvement compare to the -11.20 millions in the second quarter.

Within In Vitro & In Vivo Diagnostic Substances industry Quidelortho Corp achieved highest sequential Income Taxes growth. While Quidelortho's Income Taxes growth quarter on quarter, overall rank is .


Income Taxes Q/Q Growth Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry #
Healthcare Sector #
Overall #
Income Taxes Q/Q Growth Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry #
Healthcare Sector #
Overall #
Income Taxes Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


QDEL's III. Quarter Q/Q Income Taxes Comment
Even if Quidelortho Corp in the III. Quarter 2023 admitted Provisions for income taxes of $ -2.80 millions, some analyst mentioned, that current results point to recovery relative to the -11.20 millions in the second quarter.

Within In Vitro & In Vivo Diagnostic Substances industry Quidelortho Corp achieved highest sequential Income Taxes growth. While Quidelortho's Income Taxes growth quarter on quarter, overall rank is .


Quidelortho's 12 Months Income Taxes Growth Year on Year


Income Taxes TTM Growth

12 Months Ending
(Oct 01 2023)
12 Months Ending
(Jul 02 2023)
12 Months Ending
(Apr 02 2023)
12 Months Ending
(Jan 01 2023)
12 Months Ending
(Oct 02 2022)
Cumulative Income Taxes 12 Months Ending $ 8.01 $ 22.91 $ 57.71 $ 187.20 $ 260.45
Y / Y Income Taxes Growth (TTM) -96.93 % -92.71 % -80.31 % -4.55 % 1.16 %
Year on Year Income Taxes Growth Overall Ranking # 855 # 866 # 0 # 218 # 0
Seqeuential Income Taxes Change (TTM) -65.04 % -60.3 % -69.17 % -28.12 % -17.08 %
Seq. Income Taxes Growth (TTM) Overall Ranking # 1119 # 1082 # 0 # 1163 # 0




Cumulative Income Taxes growth Comment
Quidelortho's cumulative 12 months Income Taxes continue to drop, but on the faster rate at -96.93% year on year, at Oct 01 2023 compare to the -92.71% decrease at Jul 02 2023. If the Quidelortho's fiscal year would end at Oct 01 2023, annual Income Taxes would be $8 millions.

In the Healthcare sector 100 other companies have achieved higher trailing twelve month Income Taxes growth. While Total ranking has impoved so far to 855, from total ranking in previous quarter at 866.

Income Taxes TTM Q/Q Growth Statistics
High Average Low
5303.62 %
-112.25 %
-8471.32 %
 

Income Taxes TTM Y/Y Growth Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry # 1
Healthcare Sector # 101
Overall # 855

Income Taxes TTM Y/Y Growth Statistics
High Average Low
5303.62 %
-112.25 %
-8471.32 %
 


Income Taxes TTM Q/Q Growth Company Ranking
Within: No.
Industry # 1
Sector # 117
S&P 500 # 1119
Cumulative Income Taxes growth Comment
Quidelortho's cumulative 12 months Income Taxes continue to drop, but on the faster rate at -96.93% year on year, at Oct 01 2023 compare to the -92.71% decrease at Jul 02 2023. If the Quidelortho's fiscal year would end at Oct 01 2023, annual Income Taxes would be $8 millions.

In the Healthcare sector 100 other companies have achieved higher trailing twelve month Income Taxes growth. While Total ranking has impoved so far to 855, from total ranking in previous quarter at 866.

Income Taxes TTM Q/Q Growth Statistics
High Average Low
5303.62 %
-112.25 %
-8471.32 %
 


Income Taxes TTM Y/Y Growth Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry # 1
Healthcare Sector # 101
Overall # 855

Income Taxes TTM Y/Y Growth Statistics
High Average Low
5303.62 %
-112.25 %
-8471.32 %
 


Income Taxes TTM Q/Q Growth Company Ranking
Within: No.
Industry # 1
Sector # 117
S&P 500 # 1119




Other Income Taxes Growth
In Vitro & In Vivo Diagnostic Substances Industry Income Taxes Growth Trends and Statistics
Healthcare Sector Income Taxes Growth Statistics
Income Taxes Growth Trends for overall market
QDEL's Income Taxes Growth Ratio versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Income Taxes Growth
Lowest Ranking Income Taxes Growth
Income Taxes Growth for QDEL's Competitors
Income Taxes Growth for Quidelortho's Suppliers
Income Taxes Growth for QDEL's Customers

You may also want to know
QDEL's Annual Growth Rates QDEL's Profitability Ratios QDEL's Asset Turnover Ratio QDEL's Dividend Growth
QDEL's Roe QDEL's Valuation Ratios QDEL's Financial Strength Ratios QDEL's Dividend Payout Ratio
QDEL's Roa QDEL's Inventory Turnover Ratio QDEL's Growth Rates QDEL's Dividend Comparisons



Companies with similar Income Taxes drop for the quarter ending Oct 01 2023 within Healthcare SectorY/Y Change %Income Taxes for the quarter ending Oct 01 2023
Patterson Companies Inc -21.06%$ -21.064 millions
Champions Oncology Inc -21.43%$ -21.429 millions
Johnson and Johnson-33.43%$ -33.431 millions
Medtronic Plc-58.08%$ -58.081 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com